• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Sun pharma ppt
 

Sun pharma ppt

on

  • 825 views

 

Statistics

Views

Total Views
825
Views on SlideShare
825
Embed Views
0

Actions

Likes
0
Downloads
49
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • 250

Sun pharma ppt Sun pharma ppt Presentation Transcript

  • Project prepared and presented by: Jinia Biswas Sruti Jain Vibhav Kaushal
  • HISTORY • 1983 – Sun Pharma established with five psychiatry products and two person marketing team at Vapi, Gujarat. • 1994 – Sun Pharma went public in an issue that was oversubscribed 55 times. • 1989 – Exports to neighbouring countries began. • 2000 – Sun Pharma ranked 5th largest pharmaceutical company in India. • 2007 – Sun Pharma demerged into a separate entity Sun Pharma Advanced Research Company, the first research company to get listed on stock exchanges in India. • 2012 – Major acuisitions in US completed.
  • BOARD OF DIRECTORS Chairman – Israel Makov Managing Director – Dilip S. Shanghvi Executive Director – Sudhir V. Valia, Sailesh Desai Non-executive independent director – Hasmukh Shah, Keki M. Mistry, Ashwin Dani, S. Mohanchand Dadha.
  • AWARDS 2012  Business Leadership Of The Year - Pharmaceutical – NDTV Profit  Most outstanding Company Of The Year – CNBC TV 18 India Business Leader Award  Listed on World’s 100 Most Innovative Companies – Forbes  Listed on Asia’s Fab 50 - Forbes
  • ACUISITIONS & JOINT VENTURES Generic Business of URL Pharma , United States Dusa Pharmaceuticals Inc, United States Joint Venture with MSD Acquired Caraco Pharmaceutical Laboratories Ltd Acquired Taro Pharmaceutical Industries Ltd Acquired Inwood Laboratories Incorprated
  • SHARE PRICE As on 26th November, 2013 : BSE Rs 587.55, 7.00(+1.21%) , Volume 17,147 As on 26th November, 2013 : NSE Rs 587.70, 6.85(+1.18%), Volume 150,672
  • SUN PHARMA INDUSTRIES STOCK PRICE P/E 652.30 P/C(Based on standalone numbers) 443.17 BOOK VALUE(Rs) 41.64 PRICE BOOK(Based on standalone numbers) 13.94 DIVIDEND(%) 250.00% DIVIDEND YIELD(%) 0.43% MARKET LOT 1 FACE VALUE(Rs) 1 INDUTSRY P/E 32.03 DELIVERABLES(%) 69.85
  • CONTRIBUTION TO SENSEX COMPANY NAME INDUSTRY LAST PRICE CHANGE Rs (%) MARKET CAPITALIZATION (CRORES) CONTRIBUT ON SUN PHARMA PHARMACEUTICAL 587.70 7.15 1.23 48688.92 8.56 CIPLA DO 390.75 3.45 0.89 20393.20 2.68 DR.REDDY’S LAB DO 2438.00 -1.30 -0.05 31102.74 -0.24
  • CONTRIBUTION TO NIFTY COMPANY LAST PRICE CHANGE Rs (%) MARKET CAP(CRORES) CONTRIBUTION SUN PHARMA 589.80 8.95 1.54 122,157.25 2.07 LUPIN 853.50 2.90 0.34 38251.99 0.15 CIPLA 390.60 3.50 0.90 31362.11 0.31 RANBAXY 428.00 3.05 0.72 18110.47 0.14 DR.REDDY’S LAB 2446.80 6.65 0.27 41620 0.13
  • DIVIDEND HISTORY Financial Year Interim/F inal Rate of Dividend Dividend per equity share(Rs Face Value Book Closure From To Date of declarati of dividend 2007- 2008 Final 210% 10.50 Rs 5 27/08/08 6/09/08 6/09/08 2008- 2009 Final 275% 13.75 Rs 5 25/08/09 5/09/09 11/09/09 2009- 2010 Final 275% 13.75 Rs 5 14/09/10 24/09/10 24/09/10 2010- 2011 Final 350% 3.50 Re 1 6/09/11 16/09/11 16/09/11 2011- 2012 Interim 425% 4.25 Re 1 16/08/12 Record Date 10/18/12
  • TREND ANALYSIS
  • KEY PERFORMANCE INDICATORS INDICATOR/ YEAR TOTAL INCOME PROFIT FOR THE YEAR RESERVE & SURPLUS EARNINGS PER SHARE NET BLOCK 2008-2009 44808 18780 69414 87.8 14625 2009-2010 42123 13470 77254 65.2 15328 2010-2011 60827 18161 93798 17.5 25214 2011-2012 84910 26567 121322 25.7 29295 2012-2013 116880 29831 148862 28.8 45145
  • 21st ANNUAL REPORT FOR THE YEAR ENDED MARCH 31, 2013 Particulars Year ended March 31,2013(Rs in million) Year ended March 31, 2012(Rs in million) Total Income 26,683 43,584 Profit After Tax 5,166 16,975 Dividend on Equity Shares 5,178 4,401 Corporate Dividend Tax 880 714 Transfer to various reserves 520 2,000 Amount of dividend per equity share of Re 1 each 2.50 4.25 Book Value per equity share of Re 1 each 75 76
  • EXPENDITURE ON R & D Year ended March 31, 2013(Rs in million) Year ended March 31, 2012(Rs in million) Capital 377.2 352.1 Revenue 2725 1831.9 Total 3102.2 2184 Total R&D as a % of Total Turnover 13.8% 9.1%
  • CURRENT NEWS ON SUN PHARMA • Sun Pharmaceutical Industries Ltd gained 1 per cent after unit Taro Pharmaceutical Industries announced the start of a tender offer to buy back up to $200 million of its ordinary shares. • Sun Pharma's stake in Taro will go up to more than 69 per cent from 66 per cent should the buyback be fully subscribed. • MUMBAI: The impregnable walls around top defensive stocks such as ITC and Sun Pharma have cracked, as they have lost nearly 10% from their October peaks against NSE Nfity's fall of just a little over 1%. These stocks are among the biggest losers in benchmark Nfity during the past month.
  • • Pharma leader Sun Pharma is trading at 40 times, which is the highest among its peers. • Drug Controller General of India has ordered Sun Pharmaceutical, the country's largest drug maker by m-cap, to suspend clinical research activities at its Mumbai based bio- analytical laboratory, a move that could slow down its regulatory filings in India and overseas as well. • The company has upped its revenue growth guidance to 25% for FY14 over the previously announced range of 18-20%, but analysts are sceptical of sustainability of margins.
  • http://www.unitedworld.edu.in/Campus Ahmedabad Campus: Karnavati Knowledge Village, A/907,Uvarsad, S.G.Highway, Gandhinagar Kolkata Campus: Infinity Benchmark Tower 10th Floor, Plot - G1, Block - EP& GP, Sec - V, Salt Lake, Kolkata. Reg. Office: 407, Zodiac Square, 4th Floor Opp. Gurudwara, S.G. Road, Bodakdev, Ahmedabad.